Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Akari Therapeutics Issues 2025 End of Year Letter to Shareholders
(NASDAQ: AKTX) Delayed: 10.84 +0.69 (6.80%)
Previous Close $10.15    52 Week High $19.75 
Open $10.00    52 Week Low $7.63 
Day High $11.40    P/E N/A 
Day Low $9.65    EPS $0.00 
Volume 61,947